Chen and colleagues have also demonstrated a requirement for AKT in PTEN-deficient prostate cancer, as Akt1 haplodeficiency was found to suppress high-grade prostate intraepithelial neoplasia development within Pten heterozygous mice [133]. The gene discussed is AKT1; the disease is prostate carcinoma.